As of 2025-07-02, the Relative Valuation of Abbott Laboratories (ABT) is 208.41 USD. This relative valuation is based on P/E multiples. With the latest stock price at 136.26 USD, the upside of Abbott Laboratories based on Relative Valuation is 53.0%.
The range of the Relative Valuation is 137.39 - 342.39 USD.
| Range | Selected | |
| Trailing P/E multiples | 29.9x - 44.1x | 35.8x |
| Forward P/E multiples | 33.7x - 36.9x | 34.0x |
| Fair Price | 137.39 - 342.39 | 208.41 |
| Upside | 0.8% - 151.3% | 53.0% |
| Date | P/E |
| 2025-07-01 | 17.56 |
| 2025-06-30 | 17.53 |
| 2025-06-27 | 17.32 |
| 2025-06-26 | 17.22 |
| 2025-06-25 | 17.71 |
| 2025-06-24 | 17.79 |
| 2025-06-23 | 17.17 |
| 2025-06-20 | 17.14 |
| 2025-06-18 | 17.06 |
| 2025-06-17 | 17.05 |
| 2025-06-16 | 17.27 |
| 2025-06-13 | 17.48 |
| 2025-06-12 | 17.58 |
| 2025-06-11 | 17.43 |
| 2025-06-10 | 17.28 |
| 2025-06-09 | 17.19 |
| 2025-06-06 | 17.21 |
| 2025-06-05 | 17.26 |
| 2025-06-04 | 17.13 |
| 2025-06-03 | 17.23 |
| 2025-06-02 | 17.21 |
| 2025-05-30 | 17.21 |
| 2025-05-29 | 17.12 |
| 2025-05-28 | 17.01 |
| 2025-05-27 | 17.13 |
| 2025-05-23 | 16.92 |
| 2025-05-22 | 16.94 |
| 2025-05-21 | 17.14 |
| 2025-05-20 | 17.42 |
| 2025-05-19 | 17.47 |
| 2025-05-16 | 17.37 |
| 2025-05-15 | 17.18 |
| 2025-05-14 | 16.57 |
| 2025-05-13 | 16.63 |
| 2025-05-12 | 17.01 |
| 2025-05-09 | 17.17 |
| 2025-05-08 | 17.27 |
| 2025-05-07 | 17.26 |
| 2025-05-06 | 17.15 |
| 2025-05-05 | 17.09 |
| 2025-05-02 | 17.11 |
| 2025-05-01 | 16.86 |
| 2025-04-30 | 16.85 |
| 2025-04-29 | 16.82 |
| 2025-04-28 | 16.69 |
| 2025-04-25 | 16.60 |
| 2025-04-24 | 16.67 |
| 2025-04-23 | 16.73 |
| 2025-04-22 | 16.97 |
| 2025-04-21 | 16.74 |